Trial
NCT00428168
Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
OBEcure Ltd.
Collaborators
—
Condition
Weight Gain
Intervention
Betahistine
Why stopped
Interim Analysis result indicated the study will not show a significant benefit of the study medication on the primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-15